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Abstract
Streptococcus equi subspecies equi (S. equi) causes strangles, a highly contagious and 
serious disease in the upper respiratory tract of horses, with a worldwide distribution. 
Streptococcus equi subspecies zooepidemicus (S. zooepidemicus) is regarded as an 
opportunistic pathogen infecting horses and other animals, and is believed to be the 
ancestor of S. equi. Pathogenic bacteria have evolved excellent ways of escaping the 
immune system and other defence mechanisms or have adapted to efficiently colonise 
specific areas of the host.
The overall objective of this thesis was to study the interaction between S. equi and 
S. zooepidemicus and the host. An important feature for establishment of an infection 
and survival of the microorganism inside the host is the interaction with, and adherence 
to, host tissues. In one of the studies, a group of extracellular proteins with sequence 
similarities with the fibronectin- and collagen-binding protein FNE, were identified and 
characterised. All of the proteins bound to collagen to different degrees, and one of the 
proteins, FNEE, was shown to bind both collagen and fibronectin, and mediate a 
collagen contraction in presence of PDGF-BB. In another study, an additional IgG 
endopeptidase of S. equi (and S. zooepidemicus), called IdeE2 (IdeZ2) was described.
IdeE2 efficiently degrades horse IgG4, and together with another endopeptidase, this 
enzyme induced protection in a mouse infection model. In a continuation of the 
IdeE2/IdeZ2 study, on screening a panel of S. zooepidemicus isolates, sequence 
variation within the ideZ2 gene was discovered, resulting in three major gene 
variations. However, the variation in this gene did not reflect the origin of the isolates 
or the MLST group of the strain. Extended computer alignment with IdeS from S. 
pyogenes, revealed similarities to structures known to be important for endopeptidase 
activity. The recombinant proteins IdeZ212, IdeZ216 and IdeZ221 all degraded horse IgG 
highly efficient despite amino acid differences in between the proteins, which argues 
for the importance of these proteins in the infection process.     
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1 Introduction
1.1 General background
A vast proportion of the Earth - soil, water, the digestive tract of organisms etc.
- is inhabited by microorganisms, each adapted to its specific ecological 
habitat. The vast majority of these bacteria are harmless or even essential for 
human survival, providing nutrients and cofactors, but there are also bacteria 
that are harmful and sometimes cause infection or disease when the immune 
system of the host is compromised. These pathogenic bacteria cause many 
globally distributed diseases that can affect humans and animals. Over the 
course of evolution, the pathogenic bacteria have evolved different ways of 
evading the immune system or have various ways of colonising specific areas 
of the host. These bacteria have several strategies for escaping the host immune 
system, thereby disabling the defence mechanisms of the body. One such 
strategy is to enter the host cells quickly or imitate structures that are familiar 
to the host immune system, thereby escaping recognition and detection. The 
host immune system has its own strategies for recognising and targeting all 
foreign agents, viruses and bacteria detected inside the body. 
One group of bacteria commonly recognised as pathogenic are the different 
species within the genus Streptococcus, which belongs to the phylum 
Firmicutes and contains a wide variety of homofermentative species. 
Streptococcus equi subspecies equi (in this thesis referred to as S. equi) is 
responsible for strangles, a severe upper respiratory tract infection in horses 
and other equines. Outbreaks of strangles are common and the disease is spread 
all around the world. At present, there is no safe and efficient vaccine on the 
market.  
Streptococcus equi subspecies zooepidemicus (in this thesis referred to as S.
zooepidemicus) is believed to be the ancestor of S. equi and a broadly adapted 
pathogen. As the name suggests, it can be found in a variety of animals such as 
dogs, cats, horses and humans. It can cause infection often in connection with 
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some kind of stress, e.g. severe tissue injury or viral infection and is regarded 
as an opportunistic pathogen.   
This thesis is based on studies on the interaction between Streptococcus 
equi subspecies equi and Streptococcus equi subspecies zooepidemicus and 
their host.
1.2 The immune system
The role of the immune system is to protect the host from potentially harmful 
pathogens such as parasites, fungi, bacteria and viruses. The system is based on 
complex reaction pathways involving both cellular and biochemical signalling 
and reactions in complicated networks. The immune system is basically 
composed of two major components, innate and adaptive (acquired) immunity.
A simplified description of the immune system will be further described based 
on the following books, Cellular and Molecular Immunology and 
Grundläggande immunologi (Abbas, 2000; Brändén, 1998).
1.2.1 Innate immunity
The first line of early defence against microorganisms before actual infection 
in basically all mammals is a physical barrier such as skin, saliva, tears and 
mucosal layers. The physical barrier makes it difficult to enter the mammalian 
body, but also provides effective protection through mucus production, 
sneezing, urine and diarrhoea that enables the body to eradicate invading 
microbes. If a pathogen manages to enter this first physical barrier, a second 
line of defence is activated. The innate immune response recognises different 
components that are conserved among a broad group of microorganisms, but
are not present in mammalian cells. These structures are often essential in the 
survival of the microbe. Recognition of these structures can activate different 
pathways of a complement system, resulting in early opsonisation and 
enhanced phagocytosis of the pathogen. The activation of complement 
produces cytokines that contribute to inflammatory responses and thereby 
recruitment and activation of leukocytes. The innate immune system responds 
to repeated infection in a similar way regardless of previous exposure, i.e.
lacking a memory of previous infections. 
12
1.2.2 Adaptive (acquired) immunity
Adaptive immunity is the third line of defence that allows for stronger immune 
responses and also immunological memory for the specific pathogen. The 
adaptive immune responses develop later during the infection and take days or 
weeks to be completely effective. The adaptive system is composed of 
humoral immunity and the cell-mediated immune response. The main 
function of humoral immunity is defence against extracellular microbes and 
their products, where antibodies or receptors on B lymphocytes (B cell 
receptors) detect cell wall antigens and secreted or cell wall bound toxins and 
initiate neutralisation, opsonisation and phagocytosis, and activation of the 
complement system. The cell-mediated immune response is the response to 
intracellular microbes such as some bacteria and viruses that survive and 
proliferate inside phagocytes. The cell-mediated immune response is initiated 
by the T lymphocytes, which detect antigens of the intracellular microbes or an 
infected cell and mediate killing of the infected cell by apoptosis.    
1.2.3 Immunoglobulins (Antibodies)
Antibodies are part of the adaptive immune response and are large 
glycoproteins that have the ability to bind foreign substances. Antibodies, also 
called immunoglobulins, play an important role in the defence against bacteria 
and other microorganisms in mammals during an infection by complement
activation and phagocyte signalling. The Y-shape structure of an antibody 
comprises two identical heavy chains and two identical light chains which are 
linked together by disulphide bonds. Both chains consist of an N-terminal 
variable part creating the antigen-binding property of the antibody molecule. 
The C-terminal parts of the chains of an antibody comprise the constant part. 
Depending on the structure of the constant domains, the antibodies can be 
grouped into different classes, e.g. human immunoglobulin (Ig) A, IgD, IgE, 
IgG and IgM. The function of the variable part of an antibody is to bind to the
foreign structure of an invading organism, while the constant part of antibodies 
mediates the recruitment of specific host cells or activation of the complement 
system.     
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Figure 1. Schematic description of immunoglobulin (Ig) G. An antibody is composed of two 
chains, the heavy chain and the light chain. Each heavy chain has three constant domains (CH1-
CH3) and a variable domain (VH). The light chain contains a constant domain (CL) and a variable 
domain (VL). The Fab (antigen-binding fragment) region recognises and binds to foreign objects, 
antigens. The Fc (crystallisation fragment) region is the base for the antibody but is also involved 
in opsonisation and complement activation.   
1.3 Strangles
Strangles is a severe upper respiratory disease of horses caused by the 
bacterium S. equi. The disease has a worldwide distribution and is one of the 
most feared horse diseases due to its severity and frequency, but also due to 
economic losses when isolation restrictions are imposed on stables. The disease 
was first described and reported in 1251 by Jordanus Rufus and is one of the 
most commonly diagnosed equine diseases (Timoney, 1993).  Strangles is not 
in principle a fatal disease, although it can cause chronic illness and in severe 
cases also death (Sweeney et al., 2005; Timoney, 2004; Harrington et al.,
2002). Disease symptoms and severity are often correlated to immune status 
and age of the horse, with older horses displaying a milder version and young 
horses often developing a more severe form (Sweeney et al., 2005).
S-S
S-S
Antigen binding site
Fab
Fc
CH3
CH2
CH3
CH2
CH1 CH1
VH VH
VLVL
CL CL
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Figure 2. Horse suffering from strangles, with ruptured abscess. Photo used with kind permission 
of Vet. Nick Parkinson.
1.3.1 Clinical signs and pathogenesis
The classical description of strangles includes swelling of lymph nodes, 
abscess formation and high fever. The disease is characterised by a rapid 
increase in body temperature within the range 39-41ºC that continues 
throughout the disease, followed by coughing and a rich yellowish nasal 
discharge. The infection is initiated when S. equi invades the horse via the 
mouth or nose, attaches to the tonsils and is transported through the mucosal 
layers in the upper respiratory tract. The pathogen quickly enters the host and 
spreads via the lymphatic channels to the lymph nodes, resulting in abscess 
formation. A couple of hours after the infection, S. equi is difficult to detect on 
the mucosal surface and has moved to the lymph nodes in the pharyngeal 
region (Timoney & Kumar, 2008). In some cases the pathogen gains access to 
the circulatory system and the internal lymph nodes, thereby enabling its 
spread to other parts of the host body. This severe condition is called “bastard 
strangles” and can give rise to abscess formation in the kidneys, liver or even 
the brain. Another complication that can occur in infected horses is Purpura 
Haemorrhagica, an immune-mediated condition that causes small bleeds from 
15
oedema in the limbs, eye-lids, gums and internal organs. This may cause a
stoppage in the circulatory system and thus death (Harrington et al., 2002).
1.3.2 Transmission of bacteria and persistent carriage
S. equi can be detected in nasal discharge after 24-48 hours from the onset of 
the infection and usually persists in nasal shedding for a few weeks (Sweeney
et al., 2005; Timoney, 2004; Timoney, 1993). Transmission of S. equi is 
thought to be via contact with nasal secretions, aerosols or abscess material,
either from infected horses or from infected horses without clinical signs 
(Sweeney et al., 2005). Strangles is transmitted through direct horse-to-horse 
contact, as well as via humans, clothes, shared equipment, feed or 
contaminated water (Waller et al., 2007b; Sweeney et al., 2005).   Some horses 
that have recovered from strangles still acquire an asymptomatic subclinical 
infection in the guttural pouches. Remaining pus in the guttural pouches can in 
some cases form so-called condroids, which contain viable S. equi. These 
persistent carriers shed S. equi via normal nasal secretion. The ability of S. equi
to persist and adapt in healthy horses facilitates transmission of the bacteria 
around the world, creating sources of new outbreaks (Harris et al., 2015; 
Newton et al., 2000; Newton et al., 1997).
1.3.3 Treatment of strangles
The main focus in treating the vast majority of horses with uncomplicated 
strangles is primarily on providing the horse with good care and keeping good 
hygiene conditions, which helps the horse to recover from the infection on its 
own. In severe cases, antibiotic treatment can be suggested, although it may not 
be effective (Harrington et al., 2002). Streptococcus equi is sensitive to most 
antibiotics, with penicillin as the first choice. Some horses develop high fever 
and swollen lymph nodes, resulting in anorexia, in which case anti-
inflammatories such as phenylbutazone may be administered (Mallicote, 2015; 
Harrington et al., 2002).    
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1.4 The genus Streptococcus
The genus Streptococcus in the phylum Firmicutes contains a wide variety of 
homofermentative, chain-forming species of microorganisms. These bacteria 
were initially found in wounds in 1874 by Billroth who named them 
Streptococcus, based on the Greek streptos, meaning “twisted chain”. 
Streptococci are Gram-positive bacteria with spherical or ovoid cells with a 
diameter of 0.5-2.0 m that grow in pairs or chains. They are catalase-negative 
and most commonly facultative anaerobes that require a rich medium and 
occasionally 5% CO2 for growth. The temperature optimum for the bacteria is 
around 37 ºC, although the minimum and maximum temperature varies within 
the genus. During growth on blood agar, pathogenic streptococci produce three 
distinct types of haemolytic patterns, with streptococci that produce 
streptolysin O or S generating red blood cell haHPRO\VLVFDOOHGȕKDHPRO\VLV.
Many streptococci do not produce these haemolysins and instead cause a
discoloration of the red blood cells that creates a greenish or brownish zone 
around the colonies, FDOOHG Į KDHPRO\VLs, or no haemolysis, called Ȗ
haemolysis (Madigan, 2003). Genetically, streptococci are grouped into 
species, but traditionally streptococci and other related cocci are also
serologically divided into groups based on the presence of a specific 
carbohydrate antigen, the Lancefield serological groups A-O (Lancefield, 
1933).
Streptococci are responsible for a large number of diseases in both humans 
and animals worldwide and are found on mucus membranes of the mouth, 
respiratory and genitourinary tracts, as well as on the skin. To distinguish 
between pathogenic streptococci, they are divided into two groups, the oral and 
the pyogenic groups. The pyogenic group (Table 1) is regarded as pathogenic 
or opportunistic pathogens, the most well-studied example being the human 
serological group A bacteria streptococcus (Streptococcus pyogenes), which is 
responsible for various diseases ranging from mild infections of the skin to 
potential life-threatening infections such as bacteraemia or toxic shock.
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Table 1. The pyogenic group of streptococci
Species Lancefield
group
Haemolysis Host
S. pyogenes
S. agalactiae
S. dysgalactiae
subsp. equisimilis
subsp. dysgalactiae
S. equi
subsp. equi
subsp. zooepidemicus
subsp. ruminatorium
S. canis
S. iniae
S. parauberis
S. porcinus
S. uberis
A
B
A, C, G, L
C
C
C
C
G
-
E, P
E, P, U, V
E, P, G
ȕ
Įȕ
ȕ
ȕ
ȕ
ȕ
ȕ
Įȕ
Į-
ȕ
Į-
Humans
Humans, cattle
Humans, mammals
Cattle
Horses
Humans, mammals
Sheep, goat
Dogs
Fish, dolphins
Cattle
Pigs
Cattle
1.4.1 Streptococcus equi
Streptococcus equi is a Gram-positive, catalase-negative, facultative anaerobic
bacterium that belongs to the Lancefield group C streptococci (GCS). Three 
subspecies are included in this group, subspecies equi, subspecies 
zooepidemicus and subspecies ruminatorium.
Streptococcus equi which causes strangles is host-restricted to members of 
Equidae (Timoney, 1993). It displays ȕ- haemolysis (Table 1) and is unable to 
ferment lactose, trehalose and sorbitol. It can therefore be biochemically
distinguished from the other S. equi subspecies (Fernandez et al., 2004; Grant
et al., 1993). Another way to identify streptococcal isolates is by DNA-based 
molecular methods, for example PCR (Webb et al., 2013; Lindahl et al., 2011; 
Heather et al., 2008; Baverud et al., 2007). The genome is fully sequenced and 
available at Sanger Institute online 
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(http://www.Sanger.ac.uk/projects/Microbes). The genome sequence has a GC 
content of 41% and is about 2.3 Mbp in length (Holden et al., 2009).
Genetically, different strains of S. equi are quite conserved and it is suggested 
that S. equi originated from an ancestral strain of S. zooepidemicus through 
gene gains and losses and should therefore be considered a biovar or clone of 
S. zooepidemicus (Waller & Robinson, 2013; Holden et al., 2009; Webb et al.,
2008).
Subspecies zooepidemicus, in contrast to S. equi, is not restricted to causing
infection in equines only and can be found in a variety of animals, such as 
dogs, cats, horses and humans (Pelkonen et al., 2013; Timoney, 2004). It can 
cause infection, often in connection with some kind of stress, e.g. severe tissue 
injury or a viral infection, and is therefore regarded as an opportunistic 
pathogen (Timoney, 2004). In fact, S. zooepidemicus is the most frequently
isolated opportunistic pathogen in young horses with upper respiratory 
infections (Lindahl et al., 2013). In horses, S. zooepidemicus can cause 
different kinds of infections such as uterine, wound, and upper respiratory 
infections, to name a few. The genome of S. zooepidemicus is also fully 
sequenced (Sanger Institute) and displays a GC content of 41.5% and is 2.15 
Mbp in length (Holden et al., 2009).
Streptococcus equi subspecies ruminatorium (S. ruminatorium) was isolated 
from sheep and goats with mastitis quite recently (Fernandez et al., 2004).
Both its genotypic and phenotypic characteristics are different from those of
the other related S. equi subspecies and it has therefore been debated whether it 
belongs to the S. equi group or not.  
Figure 3. S.equi when grown on a blood agar plate. Photo used with kind permission from Jonas 
Lannergård.
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Figure 4. Cartoon showing a simplified representation of the extracellular matrix (ECM) and its 
major components e.g. proteoglycan complexes, fibronectin, collagen and integrin. 
1.5 Extracellular matrix (ECM)
The extracellular matrix (ECM) is a complex system of polysaccharides and 
proteins that contributes to the structure and function of a tissue (Becker, 2000; 
Lodish, 2000). It is responsible for cell adhesion, cell-to-cell communication 
and differentiation of cells. The ECM shows a remarkable variety of forms in 
different tissues, but the ECM is basically composed of three major classes of 
molecules. The first of these are the protein-polysaccharide complexes, called 
the proteoglycans which are space filling molecules that have a shockwave 
absorbing function in mammalian tissues. The second major class of molecules 
are the structural proteins, such as collagen and elastin, which give the ECM 
its strength and flexibility. The specialised proteins, the adhesive 
glycoproteins fibronectin and laminin, attach the ECM to cells and are the third 
major class of molecules.
The most common cell type in the ECM is fibroblasts, which maintain and 
provide a structural framework. Chondrocytes and osteoblasts are other cell 
types in the ECM and are found in cartilage and bone formation respectively.
Certain eukaryotic cell-surface receptors, including integrins, bind to 
components of the ECM, thereby mediating adherence of the cells to each 
Collagen fibers
Fibronectin
Proteoglycan complex
Integrin
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other through their interaction with the matrix. The matrix is also a reservoir 
for extracellular signalling molecules that controls differentiation and cell 
growth. 
Adherence of pathogenic bacteria to host cells and tissues via the ECM is 
considered an important step in the early bacterial infection process. The 
bacterial components interacting with the ECM are either secreted proteins or 
proteins located on the bacterial cell surface. Two major ECM components that 
are important in this study, fibronectin and collagen, are described below.
1.5.1 Fibronectin
Fibronectin is a large glycoprotein in the ECM. The function of the protein is 
reflected in its name, which originates from the Latin word fibra, meaning 
fibre, and necto, meaning attach or connect. As the name suggests, the role of 
fibronectin is to act as a connector molecule that attaches cells to various 
receptors and cells in the ECM. Fibronectin can be found in insoluble form in 
the ECM (cellular fibronectin) or in soluble form in blood or other body fluids 
(plasma fibronectin). The protein is involved in many important processes 
including cell migration in the embryo, morphology, thrombosis, growth and 
differentiation (Henderson et al., 2011; Pankov & Yamada, 2002; Lodish, 
2000). Fibronectin can bind various host substances such as fibrin, 
collagen/gelatine, heparin and cellular integrins. 
A fibronectin molecule consists of two almost identical peptides (250-280 
kDa) that are coupled together by two disulphide bridges near the C-terminal 
end of the molecules (Becker, 2000; Lodish, 2000). Each peptide is built up of 
a series of globular domains, mainly three types of homologous repeats, which
are linked by short flexible segments. The domains comprise 12 type I 
modules, two type II modules and 15-17 type III modules. The cell-surface 
binding domain contains a RGD-motif. 
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Figure 5. Schematic figure of a fibronectin chain. The chain is composed of 12 FI modules (blue), 
two FII modules (green) and 15-17 FIII modules (yellow). Major proteolytic cleavage sites are 
indicated with arrows and its respective ligand indicated. 
1.5.2 Collagen
The most abundant glycoprotein in the ECM of most mammalian cells is 
collagen. This protein maintains the structure of tissues and organs and 
accounts for about 25% of all proteins in the human body (Ricard-Blum & 
Ruggiero, 2005). The collagen proteins are a large family with up to 28 
different types presenting diverse functions and tissue distributions identified 
to date. Collagens are divided into two main classes depending on the polymers 
formed; the fibril-forming collagens (I, II, III, V and XI), which are 
characterised by a rather homogeneous group of proteins, and the nonfibrillar 
collagens, which comprise a more heterogeneous group (Bosman & 
Stamenkovic, 2003; Becker, 2000; Lodish, 2000). Collagen is a super helix 
formed by three parallel extended right-handed helices in a characteristic rope-
like structure. The protein is synthesised as a procollagen, a longer precursor, 
and undergoes hydrolysis and other modifications before forming the triple 
chain molecules. A distinguishing feature of all types of collagen backbone is a 
repetitive triplet with a glycine (G) as the first amino acid, followed by Xaa 
and Yaa where X is usually a proline (P) and Y is usually a hydroxyproline (O) 
(Zeltz & Gullberg, 2016; Gelse et al., 2003).
N C
S S
SS29 kDa 40 kDa
C
120 – 140 kDa 50 – 70 kDa
Heparin/fibrin
Gelatin/ 
collagen
Cell binding Heparin/fibrin
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1.6 Extracellular proteins and other potential virulence factors of 
S. equi
An important feature for establishment of an infection and survival of the 
microorganism inside the host is the interaction with, and adherence to, host 
tissues (Schwarz-Linek et al., 2006; Nyberg et al., 2004; Kreikemeyer et al.,
2003; Harrington et al., 2002; McElroy et al., 2002). Some pathogenic 
streptococci express different molecules in order to interact with host tissues 
and cells, or to escape the host immune defence mechanisms. Some of these 
molecules have been identified as virulence factors (Waller et al., 2011; 
Batzloff et al., 2004; Beckmann et al., 2002; Chhatwal, 2002; Hytonen et al.,
2001). Virulence factors are either expressed on the bacterial surface or 
secreted into the surroundings by the bacteria. Streptococcus equi possesses 
several different potential virulence factors including a hyaluronic capsule, 
exotoxins, proteases, various surface-anchored proteins and the antiphagocytic 
SeM protein. 
1.6.1 Capsule
The capsule is regarded as an important virulence factor for many streptococci 
(Waller et al., 2011; Anzai et al., 1999). A carbohydrate capsule composed of 
hyaluronic acid surrounds the bacteria and hides it from the host immune 
system. The reason for evading the immune system is because hyaluronic acid 
is also naturally occurring in mammals. The capsule also complicates 
attachment of macrophages to the bacteria and is greatly influenced by the age 
of the culture in vitro, where young cultures are highly encapsulated and
cultures after 24 h barely have detectable capsules, suggesting increased 
virulence of young cultures (Harrington et al., 2002). The capsule could also 
have an important function for the surface-exposed hydrophobic proteins by 
covering the active sites of the proteins, thereby maintaining their structure and 
function, as well as hindering aggregation(Srivastava & Barnum, 1983).
The presence of a capsule varies among the less virulent S. zooepidemicus
but has been found in almost all S. equi strains investigated (Wibawan et al.,
1999). In a recent study, Steward et al. (2016) showed that a reduced capsule 
phenotype is not due to genetic variation, but is instead supported by 
differences in gene transcription (Steward et al., 2016).
1.6.2 Surface proteins
Many of the extracellular proteins situated on the bacterial cell surface share a 
common structural organisation, enabling identification of certain domains and 
motifs. Many of the cell wall-anchored proteins are attached to the cell by the 
C-terminal sorting signal, starting with an amino acid sequence motif LPxTG. 
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Other cell wall-anchoring mechanisms are the N-terminal linkage displayed by
lipoproteins or hydrophobic interactions. 
M-proteins were first described in streptococci in the late 1920s
(Lancefield, 1928). M-proteins or M-like proteins are described as cell surface 
proteins that bind fibrinogen and have antiphagocytic activity, and this is one 
of the most widely studied group of bacterial virulence factors (Staali et al.,
2003). The antiphagocytic effect of M-proteins depends on inhibition of C3b (a 
complement factor) deposition on the bacterial surface or binding to fibrinogen 
(Carlsson et al., 2005) but also on capsule formation (Timoney et al., 2014).
Streptococcus equi possesses two homologues of an M-like protein, SzPSe and 
SeM (also known as FgBP) (Timoney et al., 1997; Timoney et al., 1995; 
Srivastava & Barnum, 1983). The SeM and SzPse proteins show low 
homology and are only distantly related (Timoney et al., 1997; Timoney et al.,
1995). The less virulent S. zooepidemicus also has two homologues of M-like 
proteins, SzP and SzM (Velineni & Timoney, 2013; Kelly et al., 2006; 
Timoney et al., 1997). Studies have shown that the SeM protein of S. equi is an 
important virulence factor where S. equi mutants lacking the SeM gene where 
unable to colonize infected horses (Timoney et al., 2014).
One example of a cell wall-anchored protein regarded as a virulence factor 
is CNE from S. equi (Lannergard et al., 2003). CNE binds to native fibrillary 
collagen types I, II and III with high affinity and is believed to be important in 
general adhesion to host tissues (van Wieringen et al., 2010). It has also been 
suggested that CNE could be the accessory pilin of S. equi (Waller et al.,
2011). To analyse the protective effect of CNE as an antigen in a vaccine Flock 
et al. (2006) used the recombinant protein in an experimental mouse model 
resembling S. equi infection in the horse and found that antibodies to CNE
were able to partially block (75%) the binding of S. equi to immobilised 
collagen. Moreover, recombinant CNE was included in a trial of a multi 
component vaccine that conferred protection against S. equi in horses (Guss et 
al., 2009).
Another cell wall-anchored protein in S. equi is EAG (ZAG in S.
zooepidemicus). EAG is a multi-binding protein that ELQGV ,J* Į2-
macroglobulin and albumin (Lindmark et al., 2001; Jonsson et al., 1995). EAG 
ELQGVWRĮ2-macroglobulin in the N-terminal part of the protein, followed by an 
albumin-binding region and the IgG-binding part in the C-terminal end. EAG
was also included in the multi-component vaccine that protected horses from 
strangles in the trials by Guss et al. (2009). 
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Seven different collagen-like proteins (SclC-SclI) have been reported in S. 
equi. Each of these seven proteins displays a unique N-terminal domain with as 
yet unknown functions in S. equi (Karlstrom et al., 2006; Karlstrom et al.,
2004). One of the collagen-like proteins, SclC, was included in a vaccination 
experiment together with six other potential virulence factors of S. equi that 
resulted in good protection of the horses in a strangles challenge (Guss et al.,
2009; Waller et al., 2007a).
In a study by Lannergård et al. (2005), FNEB a cell wall-anchored protein 
that binds fibronectin was described. FNEB specifically binds to the 29-kDa 
fragment on fibronectin and the binding activity on FNEB is located on the C-
terminal part of the protein. It has been suggested that FNEB mediates binding 
of fibronectin to S. equi cells grown in vitro (Lannergard et al., 2005).
1.6.3 Secreted proteins and toxins   
Streptococcus equi LV D ȕ-haemolytic bacterium that produces a secreted 
protein called streptolysin S-like toxin (SLS) that is responsible for the 
characteristic cleared zone on blood agar (Waller et al., 2011; Flanagan et al.,
1998). The activity of streptolysin S-like protein requires a carrier molecule, 
e.g. albumin or double-stranded RNA. The streptolysin complex binds to 
neutrophils and macrophages, forming transmembrane pores and thereby 
permitting osmotic lysis of the cells (Timoney, 2004). The exact role of this 
toxin is not fully understood, but the lysis of cells is intended to supply the 
bacteria with essential nutrients(Harrington et al., 2002).
Streptokinase is another secreted protein of S. equi suggested as a virulence 
factor. This protein activates equine plasminogen which hydrolyses fibrin clots
and thereby facilitates dispersion of the bacteria in the tissue (McCoy et al.,
1991).
Evasion of phagocytosis is an important feature in virulence. Streptococcus
equi possesses a couple of proteins predicted to be secreted in order to inhibit
phagocytosis.
Protein Se18.9 inhibits phagocytosis through binding factor H, which 
regulates the alternative complement pathway by reducing the C3 deposition 
on S. equi (Tiwari et al., 2007). All S. equi strains tested to date produce
Se18.9 but only one of 140 strains of S. zooepidemicus suggesting, for S. equi, 
an evolutionary important gene (Waller et al., 2011; Holden et al., 2009).
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Another secreted protein with anti-phagocytic properties is S. equi glycosyl 
hydrolase EndoSe (Flock et al., 2012). EndoSe inhibits IgG binding to Fc 
receptors by hydrolysing the sugar substituents of IgG, thereby damaging the 
antibacterial effect on IgG (Flock et al., 2012).
Streptococcus equi encodes two IgG-degrading enzymes called IdeE and 
IdeE2 (Se44.2) (IdeZ and IdeZ2 in S. zooepidemicus) (Hulting et al., 2009; 
Lannergard & Guss, 2006). IdeE cleaves horse IgG, thereby reducing IgG 
recognition by the host immune system (Lannergård 2006). IdeE has also been 
suggested to have anti-phagocytic properties by blocking phagocytosis in vitro
(Timoney et al., 2008), although the role of the endopeptidase in S. equi
infection is currently uncertain (Liu & Lei, 2010). IdeE together with IdeE2
significantly improved the efficiency of the multi-component subunit vaccine 
tested by Guss et al. (2009). IdeE2 also degrades IgG from human and cleaves 
equine IgG highly efficiently (Hulting et al., 2009). IdeE2 is discussed further 
in Chapter 2 of this thesis.
Superantigens are powerful immune-stimulatory disease-causing toxins 
produced by certain bacteria such as S. pyogenes and Staphylococcus aureus.
The superantigens cause activation of T-cells, which produces a release of 
enormous amounts of cytokines, leading to an obsessive inflammatory 
response that overloads the host body, resulting in fever and multi-organ 
failure (Alouf & Muller-Alouf, 2003). Streptococcus equi has acquired four 
mitogenic exotoxins/ superantigens; SePE-H, SePE-I, SePE-Lse and SePE-Mse 
(Paillot et al., 2010a; Paillot et al., 2010b; Proft et al., 2003; Artiushin et al.,
2002). These superantigens contribute to many of the severe symptoms 
characteristic of strangles (Paillot et al., 2010b; Timoney, 2004; Anzai et al.,
1999). Three of the superantigens, SePE-I, SePE-Lse and SePE-Mse, stimulate 
proliferation of equine PBMCs (peripheral blood mononuclear cells) in vitro
(Paillot et al., 2010b; Proft et al., 2003; Artiushin et al., 2002).
Table 2. Extracellular proteins of S. equi and S. zooepidemicus. Only published proteins are 
included. 
Protein Anchored
/ secreted
Function S. 
zooepidemicus
Reference
CNE
EAG
EndoSe
Anchored
Anchored
Secreted
Cn-binding
Į2M-, albumin-, IgG-binding
Evasion of immune system
CNE
ZAG
EndoSz
Lannergård et al. 2003
Jonsson et al. 1995
Flock et al. 2012
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FNE
FNEB
IdeE
IdeE2
SclC-SclI
Se18.9
SeM
SePE-H
SePE-I
SePE-Lse
SePE-Mse
SFS
SzPSe
Secreted 
Anchored
Secreted
Secreted
Anchored
Secreted
Anchored
Secreted
Secreted
Secreted
Secreted
Secreted
Secreted
Fn- and Cn-binding
Fn-binding
IgG-endopeptidase
IgG-endopeptidase
Unknown
Factor H-binding
Fg- and IgG-binding
Exotoxin
Exotoxin
Exotoxin
Exotoxin
Fn-binding
Fg-binding
FNZ
FNZ2
IdeZ
IdeZ2
-
-
SzM
-
-
SZEL
SZEM
SFS
SzP
Lindmark et al. 1996
Lannergård et al. 2005
Lannergård et al. 2006
Hulting et al. 2009
Karlström et al. 2006
Tiwari et al. 2007
Timoney et al. 1985
Artushin et al. 2002
Artushin et al. 2002
Proft et al. 2003
Proft et al. 2003
Lindmark et al. 1999
Timoney et al. 1997
Some of the secreted proteins of S. equi bind to soluble components in body 
fluids or to components in the ECM. One example of this protein is the 
fibronectin binding protein SFS. Due to its non-exciting cell-wall anchoring 
motif, SFS is predicted to be secreted, but the protein has not been detected in 
growth cultures and expression of SFS in vitro is very low (Lindmark & Guss, 
1999). SFS contains a GEXGE amino acid motif known to be conserved in 
other fibronectin-binding proteins such as FNZ from S. zooepidemicus. Studies 
have suggested that SFS forms a stable complex with fibronectin in a two-step 
binding process (Ma et al., 2015).
Another secreted protein of S. equi is FNE (FNZ in S. zooepidemicus). FNE 
binds to both fibronectin and collagen and lacks a cell-wall anchoring motif 
due to a deletion in the fne gene resulting in a stop codon in the open reading 
frame (ORF) creating a truncated protein missing the C-terminal part FNZ 
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protein in S. zooepidemicus (Liden et al., 2006; Lindmark et al., 2001). FNE 
specifically binds to the 40 kDa collage/gelatine-binding domain (GBD) of 
fibronectin (Lindmark et al., 2001; Lindmark et al., 1996). Studies have shown 
that FNE mediates interaction between fibronectin and native collagen type I in 
a collagen gel contraction model, creating a fibronectin-FNE-collagen fibre 
complex (Liden et al., 2008). Moreover, the crystal structure of FNE has been 
established to show similarities to a minor pilus protein of S. pyogenes
(Tiouajni et al., 2014).
In addition to FNE the genome of S. equi encodes four putative FNE-like 
proteins that bind to collagen (FNEC, FNED, FNEE and FNEF) of which one 
is predicted to be cell wall-anchored and binds both fibronectin and collagen. 
These FNE-like proteins are further discussed in Chapter 2 in this thesis.       
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2 Present investigation
2.1 Aims of the present investigation
The overall objective of this thesis was to study the interaction between S. equi
and S. zooepidemicus and the host. Previous research has shown that both S. 
equi and S. zooepidemicus express, or have the genetic potential to express, a
great number of extracellular proteins that interact or are suspected to interact 
with components present in different structures or body fluids of the host
(Holden 2009). It is generally believed that the extracellular bacterial proteins
contribute in various ways to the virulence of the bacteria, making it interesting 
to study these interactions. 
In this thesis the focus was directed on two types of extracellular proteins. 
The first type was soluble proteins with specific IgG endopeptidase activity. 
Since IgG is a crucial component of the immune system, the activity of the 
bacterial endopeptidases should interfere with the host immune defence. The 
second type of protein studied was the FNE-like family of bacterial proteins,
where the majority of members should be anchored to the bacterial cell surface. 
These types of fibronectin- and/or collagen-binding proteins are suggested to 
affect adhesion of the bacterium to the host or the connective tissue during an 
infection.
2.2 Results and Discussion 
2.2.1 IgG endopeptidases of S. equi and S. zooepidemicus
Immunoglobulin G plays a central role in the host in the protection against 
invading bacteria and other microorganisms. Binding of IgG to bacteria 
facilitates opsonisation, phagocytosis and complement activation. Furthermore,
the binding of IgG can also mediate inactivation of bacterial adhesins and 
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toxins. Antibodies (immunoglobulins) are Y-shaped large glycoproteins that 
are part of the adaptive immune response (see section 1.2.3). 
Some pathogenic bacteria have evolved different mechanisms to escape the 
host immune response by expressing and secreting proteins that interact with 
antibodies. Binding to IgG with specific receptors for the Fc region (CH2-CH3),
thereby enabling the interaction between Fc-receptors on phagocytes, is one 
way of interaction (exhibited by SeM and EAG of S. equi). Another approach
is to inhibit the interaction between Fc receptors on phagocytes and IgG, either 
by hydrolysis of sugars on IgG (EndoSe) or by cleavage of the IgG molecule 
(Flock et al., 2012; Collin & Olsen, 2001). In S. pyogenes, a cysteine protease, 
IdeS (Mac-1), has been shown to cleave IgG in a two-step reaction, resulting in 
separation of the Fab and Fc part with high specificity and efficiency, thereby 
preventing phagocytosis by leucocytes (Barnett et al., 2015; Persson et al.,
2015; Vindebro et al., 2013; Brezski & Jordan, 2010; Akesson et al., 2006; 
Vincents et al., 2004; von Pawel-Rammingen & Bjorck, 2003; Lei et al., 2002; 
von Pawel-Rammingen et al., 2002; Lei et al., 2001). Studies have shown that 
IdeS (Mac-1 and Mac-2) displays ERWK,J*GHJUDGLQJDFWLYLW\DQG)FȖUHFHSWRU
binding (Soderberg et al., 2008; Soderberg & von Pawel-Rammingen, 2008).
A homologue of IdeS has also been reported in Streptococcus suis (S. suis)
with endopeptidase activity with high specificity and efficiency towards IgM 
(Seele et al., 2015; Seele et al., 2013). A recent study described another 
cysteine protease that specifically cleaves porcine IgG at the hinge region in S. 
suis (Spoerry et al., 2016).
An IdeS-like protein has previously been described in S. equi and S. 
zooepidemicus (IdeE and IdeZ respectively) (Lannergard & Guss, 2006). These 
enzymes efficiently degrade IgG molecules from a variety of mammals such as 
humans, dogs and guinea pigs. IdeE and IdeZ cleave IgG subclasses containing 
the LLGGP substrate binding site, suggesting a similar specificity as IdeS
(Lannergard & Guss, 2006). A study by Timoney (2007) reported 
antiphagocytic activity of IdeE on equine neutrophils, where the binding was 
suggested to be mediated through the integrin-binding motif RGD present in 
the IdeE protein However, the main antiphagocytic activity has been 
questioned and remains unclear (Liu & Lei, 2010).
An additional IgG endopeptidase was described in both S. equi and S. 
zooepidemicus (IdeE2 and IdeZ2 respectively) in Paper I of this thesis. In that 
study, purified IgG from a variety of animals, including humans and horses,
was incubated with IdeE2 and IdeZ2. These endopeptidases showed high 
enzymatic activity to horse and human IgG and only weak activity to pig, goat 
and bovine IgG. In order to study the endopeptidase activity in a more complex 
system, strains of S. equi and S. zooepidemicus were incubated with THBY 
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(Todd-Hewitt broth supplemented with yeast extract) supplemented with horse 
serum (Paper I). Supernatants of S. equi contained a degradation product of 
IgG4. To analyse whether this degradation product was due to IdeE or IdeE2 
enzymatic activity both enzymes were incubated, either separately or in a mix, 
together with horse serum. The results showed that in fact IdeE2 alone
efficiently degrades IgG4. IdeE2 and IdeZ2 lack the integrin-binding motif 
present in IdeE, IdeZ and in IdeS and it is therefore doubtful whether 
IdeE2/IdeZ2 can mediate host cell binding or not. IdeE and IdeE2 were also 
used to immunise mice followed by experimental infection in order to evaluate 
these enzymes as vaccine candidates (Paper I). Both enzymes induced 
protection in an experimental infection and challenge model in mice. Mice 
intranasally vaccinated with IdeE2 showed a significant reduction in weight 
loss and nasal colonisation of S. equi compared with the control group. Since 
IdeE2 has no enzymatic activity against mouse IgG, the protective effect in 
mice was quite unexpected. One possible explanation could be that a portion of 
the protein is exposed on the bacterial surface for a short period before being 
secreted, which could lead to opsonisation of the bacteria in vaccinated 
animals. However, IdeE2 could have other, as yet unknown functions apart 
from the enzymatic activity studied here, which is inhibited by the vaccination 
process. IdeE and IdeE2 have also been used to vaccinate Welsh mountain 
ponies, together with five other recombinant proteins (Septavacc), in order to 
evaluate their ability to induce protection (Guss et al., 2009). Vaccination with 
Septavacc led to 85% protection in horses when challenged with S. equi (Guss
et al., 2009). However IdeE2 failed to protect horses when combined with 
other proteins from S. equi in a vaccination trial by Timoney et al. (2007). 
In a recent study of an isolate of S. equi showing a mixed phenotype lacking 
the mucoid capsule, IdeE and IdeE2 were upregulated in the reduced capsule 
variant, suggesting a broad feedback effect when S. equi adapts to the host 
environment, but also showing the contribution of IdeE and IdeE2 to virulence 
(Steward et al., 2016). Data from other studies also indicate that IdeE2, 
together with SeM and Se75.3 (SEQ2190), are the proteins most differentiated 
in immune responses of horses with respiratory infections caused by S. equi
(Velineni et al., 2015). Another study has shown that the expression of IdeE2 
in S. equi was effected by a peptidyl-propyl isomerase (PrsA/PrtM), a protein 
involved in secretion of several extracellular proteins S. equi (Ikolo et al., 
2015).
On PCR screening a panel of S. zooepidemicus isolates, only one of 10 
isolates showed presence of the ideZ2 gene (Paper I). Further screening of the 
ideZ2 gene showed that it varies in sequence, displaying three main different 
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gene variations named ideZ221, ideZ212 and ideZ216 (Paper III). However, the 
variation in this gene did not reflect the origin of the isolates or the MLST
group of the strain (Paper III). The IdeZ212 protein is similar to a Mac-1-like 
IgG endopeptidase of a human isolate of S. zooepidemicus previously 
described (Beres et al., 2008), while IdeZ216 seems to be novel. To investigate 
the endopeptidase activity of the different IdeZ2 proteins, the recombinant 
proteins were incubated with a selection of antibodies from a variety of 
species. The proteins displayed, despite of sequence variation, the same IgG 
endopeptidase activity to IgG from human and horse (Paper III). In order to 
further investigate the degradation activity of the IdeZ2 variants in a more 
complex environment, S. equi and S. zooepidemicus cells were grown in 
THBY supplemented with either horse serum (10%) or horse blood (1%, 5%, 
10%). Following 24 h incubation, all the supernatants of S. equi showed an IgG
degradation product, whereas only S. zooepidemicus strains grown in the 
presence of horse blood displayed an IgG degradation product (Paper III). The 
crystal structure of the IgG cleaving enzyme IdeS from S. pyogenes have been 
determined (Agniswamy et al., 2006; Wenig et al., 2004). In order to analyse 
the structure of the IdeZ2 proteins, a computational alignment to IdeS was 
performed, which showed high similarities in the regions known to be 
important for IgG cleavage. Furthermore, the alignment showed that the IdeZ2 
proteins (and IdeE2) have long insertions in the N-terminal part compared to 
IdeS, and that IdeZ216 has a long C-terminal extension. 
2.2.2 FNE belongs to a family of fibronectin-binding and collagen-binding 
proteins of Streptococcus equi
Bacterial infection usually involves several steps such as adherence, invasion
and colonisation. The initial adherence to host cells and structures is initiated 
by structures of the cell surface of the bacteria. Streptococcus equi possesses 
several different adhesins including CNE, which specifically binds to collagen 
(Lannergard et al., 2003), SFS and FNEB, which bind to fibronectin
(Lannergard et al., 2005; Lindmark & Guss, 1999) and FNE (Lindmark et al.,
2001). Other studies have confirmed that FNE binds both fibronectin and 
collagen (Liden et al., 2006; Lindmark et al., 2001; Lindmark et al., 1996).
Previous studies of the biological implication of this interaction in a eukaryotic 
collagen-gel contraction model showed that FNE enhanced the binding of 
soluble fibronectin to immobilised collagen and in vitro and also lowered the 
interstitial fluid pressure (IFP) in vivo (Liden et al., 2008; Liden et al., 2006).
A BLAST search of the genome of S. equi strain 4047 showed that this 
strain encodes several FNE similar proteins (Paper II). Four ORFs of putative 
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FNE-like proteins with specific similarities to FNE and FNEB were found.
These proteins are referred to hereafter as FNEC, FNED, FNEE and FNEF. 
Three of the proteins display the characteristic C-terminal membrane spanning 
region and wall-anchoring sortase site LPXTG. The fned gene is interrupted by 
a stop codon, resulting in a truncated protein and is therefore predicted to be 
secreted into the medium similarly to FNE. The fibronectin- and/or collagen-
binding regions of the FNE-like proteins are located in the N-terminal parts of 
the proteins and the C-terminal parts either contain collagen-like repeats 
(FNEC, FNEF) or P/K- rich repeats (FNEE) or are predicted not to be 
transcribed (FNED). An alignment of the different FNE-like proteins showed 
areas of conserved residues between all proteins.
The mature recombinant proteins, FNE-FNEF, were analysed using a 
microwell assay with radiolabelled plasma fibronectin and collagen type I
(Paper II). The wells were coated with respective mature recombinant protein,
labelled fibronectin or labelled collagen added and the specific binding was 
measured. In that assay, FNEE was the only recombinant protein, apart from 
FNE, found to bind both collagen and fibronectin. The remaining three FNE-
like proteins bound soluble collagen (Paper II).
To further analyse the binding activity, the FNE-like proteins, including 
FNE and FNEB, were sub-cloned using the GST system. Using a microwell 
binding assay, biotinylated bovine fibronectin and collagen and were added to 
wells previously incubated with the GST-tagged proteins. The binding assay 
showed that FNE-GST, FNEB-GST and FNEE-GST were able to bind to 
soluble fibronectin, while no detectable binding of FNEC-GST, FNED-GST 
and FNEF-GST to fibronectin was observed. All GST-tagged proteins except 
FNEB-GST displayed binding to collagen type I although FNED-GST showed 
remarkably lower binding activity than the other fusion proteins (Paper II).
In order to analyse the specific binding of the GST-tagged proteins to 
proteolytic fragments of fibronectin, 30-kDa or 45-kDa were used in a 
microwell assay. The results showed that only FNEB-GST was able to bind to
the 30-kDa fragment of fibronectin, which is in agreement with previous 
findings (Lannergard et al., 2005). The results using the 45-kDa fragment
showed that FNEE-GST binds to this part of fibronectin. However, no binding 
of FNE-GST to 45-kDa was detected, although previous studies have shown 
that FNE binds to the GBD domain of fibronectin (Tiouajni et al., 2014; 
Lannergard et al., 2005). One explanation could be that the proteolytic 
fragment was produced with different cleaving enzymes in Paper II and was 
therefore not identical to that used in previous studies.
Using biotinylated FNE-GST, the competition of binding to fibronectin and 
collagen of the GST-tagged proteins was tested in a microwell assay. 
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Microwells coated with fibronectin or collagen was incubated with different 
concentrations of recombinant fusion protein together with biotinylated FNE. 
The binding was detected using HRP-conjugated streptavidin. The results 
showed that the binding of biotinylated FNE-GST to fibronectin was inhibited 
by FNEE-GST and that the binding of FNE-GST to collagen was inhibited by 
FNEC-GST, FNEE-GST and FNEF-GST. The FNE binding site to procollagen 
type I has previously been reported to be located 122 nm from the C-terminus
(van Wieringen et al., 2010). The results from the competition assay in Paper 
II suggested that the collagen binding of FNEC-GST, FNEE-GST and FNEF-
GST is located at the same site or sufficiently close for steric hindrance. 
In order to further investigate the binding of FNE-GST and FNEE-GST to 
fibronectin, competition binding assays were performed using the fibronectin-
binding protein SFS. The binding site in SFS to fibronectin are localised to the 
89FI module of the GBD domain according to recent report (Ma et al., 2015).
The results showed that SFS inhibits binding of both FNE-GST and FNEE-
GST to fibronectin, confirming the location of binding for these proteins
(Paper II).
The binding site of CNE to collagen has previously been reported (van 
Wieringen et al., 2010; Lannergard et al., 2003). To analyse whether CNE 
could inhibit binding of FNE-GST and FNEE-GST to collagen, further 
competition binding analysis was performed. No inhibition of binding was 
detected, suggesting another binding location than CNE to collagen type I
(Paper II).
A set of deletion clones of FNE and FNEE was also produced in order of 
mapping the binding domains of respective protein to fibronectin and collagen. 
The results showed that the fibronectin binding in both FNE and FNEE was 
located in the C-terminal region. The collagen binding was located to the N-
terminal part of the proteins (Paper II).
Recent studies have shown that an internal thioester bond is present in FNE 
(Tiouajni et al., 2014) and Walden et al. (2015) reported that the fibronectin-
binding protein Sfbl from S. pyogenes also contains a thioester which forms a 
covalent bond between Sfbl and fibrinogen. Based on the similarities of the 
FNE-like proteins and presence of a possible thioester bond in all of the 
proteins except FNED, gel-shift experiments were performed. The GST-tagged 
FNE-like proteins were incubated with collagen type I. After incubation prior 
to SDS-PAGE analysis, the VDPSOHVZHUHPL[HGZLWKȕ-mercaptoethanol and 
SDS and thereafter boiled. The results demonstrated that FNE, FNEC, FNEE 
and FNEF displayed a gel-shift indicating a binding that resists harsh 
treatments, suggesting covalent binding to collagen type I (Paper II).
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The interaction of the FNE-like proteins with fibroblasts was also 
investigated using a collagen gel contraction model described previously
(Reyhani et al., 2014). The different FNE-like proteins were added to the 
collagen gels and the contraction measured at different time points using an 
inverted light microscope. The results of these experiments showed that, as 
previously reported (Liden et al., 2008), FNE mediates a contraction due to 
dual binding activity to both fibronectin and collagen. FNEE and FNED can 
also enhance a contraction in presence of PDGF-BB in this system. The finding 
that FNEE also mediates contraction is in agreement with the suggestion that, 
as in the case with FNE, dual binding activity is needed to enhance contraction. 
Surprisingly, although lacking fibronectin-binding activity and with only weak 
collagen-binding activity, FNED enhanced contraction. At the moment there is 
no explanation for this, although other as yet unknown functions of the FNED 
proteins cannot be ruled out (Paper II).        
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“I know one thing: that I know nothing”
Socrates
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3 Concluding remarks and future 
perspectives 
Pathogenic bacteria produce different virulence factors that contribute to their
ability to adhere and colonise the host or avoid the host immune system. This
thesis showed that S. equi, the causative agent of strangles in equines,
possesses two different types of potential virulence factors that interact with
components of the host ECM or interferes with the host immune system. 
Paper I and paper II describes the identification and characterization of two 
novel IgG endopeptidases IdeE2 of S. equi and IdeZ2 of S. zooepidemicus.
Compared to the previous described IgG endopeptidases from these 
subspecies, IdeE and IdeZ, the IgG cleavage pattern of IdeE2 and IdeZ2 is 
narrower. However, both IdeE2 and IdeZ2 cleave IgG from human and horse 
efficiently which are interesting since IdeE and IdeZ cleaves horse IgG poorly. 
Sequence alignment shows that the enzymes shows pairwise similarities 
between IdeE and IdeZ and between IdeE2 and IdeZ2 but the similarities are 
much lower when the two groups are aligned. Comparison of the S. equi and S.
zooepidemicus IgG endopeptidases with the IgG endopeptidase IdeS reveals 
that the critical amino acids important for IgG cleavage in IdeS are also present 
in the S. equi and S. zooepidemicus enzymes and the regions in proximity of 
these amino acids are conserved in IdeE, IdeZ, IdeE2 and IdeZ2. While IdeE2 
protein seems to be well conserved among different isolates, like the IdeE and 
IdeZ, the IdeZ2 protein was found to display sequence variation forming three 
major groups of IdeZ2 proteins. The differences in the IdeZ2 proteins could not 
be correlated to either type of infection, origin of the host or to MLST group of 
the S. zooepidemicus isolate. A computational model aligning IdeS and the 
different IdeZ2 proteins (and IdeE2) were produced showing that the main 
changes in the structures were in the postulated loops of the proteins and the 
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regions responsible for endopeptidase activity are well conserved within the 
three groups.
In order to confirm the structures of the IdeZ2 proteins and also IdeZ, IdeE 
and IdeE2 proteins, determination of the crystal structures of all proteins would 
give the answer. To further investigate the role of the Ide-proteins it should 
also be interesting to investigate if these proteins binds to certain antibodies, 
although no enzymatic activity have been observed, to investigate if they like 
e.g. streptococcal protein G or S. aureus protein A can inhibit other functions 
of the antibodies e.g. complement activation. Further analysis of functional 
properties of the extended N-terminal the IdeE2 and IdeZ2 proteins and the C 
terminal part of the IdeZ216 would also be interesting for the future research. 
The regulation of expression the Ide-proteins would also be an important field 
of research. Today we do not know if or when the expression occurs during an 
infection or what induce expression. However, IdeE and IdeE2 induced 
protection in mice when used as vaccine candidates (Paper I) and have been 
used in a horse vaccination trial, where they gave a good protection in horses 
when combined wither other recombinant proteins (Guss et al., 2009) results 
that suggests that these type of proteins are important in the infection process.  
In paper II four FNE-like proteins in S. equi that bind to fibronectin and/or 
collagen were identified and characterized. FNE, FNEB and FNEE bind to 
different parts of fibronectin, whereas FNE, FNEC, FNEE and FNEF bind to 
collagen type I in a probable covalent manner. FNED display a weak collagen 
binding which most likely depends on the lack of postulated critical region in 
C-terminal end of the protein. Interestingly FNE, FNEE and to a minor degree 
FNED all enhanced contraction in a collagen gel contraction model, a model 
that previous been used to investigate the activity of FNE. Mice experiments 
have shown that FNE can normalize lowering of interstitial fluid pressure by 
stimulating connective tissue cell contraction (Liden et al., 2008) suggesting a 
biological role of FNE. While FNE and most probably FNED are secreted 
proteins the FNEE have the characteristics of being a cellwall bound protein 
and the biological implication of this in relation to collagen contraction 
remains to be investigated. At moment the expression of the FNE-like proteins 
in vivo and their biological role and impact in the infection process remains to 
be investigated. Those studies should also include the FNE-like proteins in S. 
zooepidemicus. Streptococcus equi is a host-restricted horse pathogen, while S.
zooepidemicus can cause infection in a variety of species and in various parts 
of the host. Thus it would be interesting to investigate if the FNE-like proteins 
in S. zooepidemicus have a similar binding activity to fibronectin and/or 
collagen.
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4 Populärvetenskaplig sammanfattning
Kvarka är en anmälningspliktig mycket smittsam övre luftvägssjukdom, 
orsakad av bakterien Streptococcus equi underart equi (S. equi), som drabbar 
hästdjur. Sjukdomsförloppet vid kvarka inleds då bakterien infekterar 
slemhinnan i hästens mule, varifrån bakterierna sprider sig via det lymfatiska 
systemet till lymfkörtlar i hästens huvud och hals. En häst som insjuknar i 
kvarka får feber, svullna lymfknutor på huvudet och halsen och tjockt varigt 
näsflöde. Sjukdomen smittar vid kontakt mellan hästar men även vid kontakt 
med kontaminerat material så som vattenhinkar, grimskaft och boxinredning. 
Även människor kan föra smittan vidare inom och mellan stall via händer och 
kläder efter kontakt med infekterade hästar. Ett kvarkautbrott kan pågå i många 
veckor och orsakar förutom lidandet för hästarna ofta ekonomiska 
konsekvenser på grund av karantänbestämmelser vilka leder till inställd 
verksamhet såsom tävlingar och inställda ridlektioner. 
Streptococcus equi underart zooepidemicus (S. zooepidemicus) betraktas 
vanligen som en opportunistisk patogen i luftvägarna hos häst, d.v.s. bakterien 
kan finnas hos friska hästar men orsaka sjukdom om hästens immunförsvar är 
nedsatt. S. zooepidemicus kan, till skillnad mot S. equi, orsaka andra typer an 
infektioner hos häst så som sårinfektioner, ledinfektioner och infektioner i 
livmodern. Dessutom kan S. zooepidemicus orsaka infektion hos andra 
mammalier, i sällsynta fall även hos människa. 
Kunskapen om S. equi och S. zooepidemicus förmåga att orsaka sjukdom är 
inte fullständigt klarlagt. Bakterierna kan producera flera olika virulens 
faktorer vilka interagerar med värddjuret. Dessa virulens faktorer kan tex. vara 
extracellulära proteiner vilka är förankrade i cellväggen på bakterien eller 
extracellulära proteiner som transporteras ut ur cellen till den omgivande 
miljön. Att identifiera och förstå funktionen hos dessa proteiner är en mycket 
viktig del i förståelsen i infektionsprocessen.
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Syftet med projektet var att identifiera och studera extracellulära 
cellytebundna och sekreterade (potentiella virulens faktorer) hos S. equi och S. 
zooepidemicus vilka har betydelse i interaktionsprocessen mellan bakterien och 
värden. 
S. equi producerar ett okänt antal virulens faktorer som på olika sätt 
interagerar med värddjuret, hästen. En viss grupp av virulens faktorer, kallade 
adhesiner eller receptiner, har visat sig viktiga när bakterien ska binda till 
strukturer hos värden vilket underlättar och möjliggör kolonisation. Adhesion 
till komponenter i värdens extracellulära matrix (ECM) har visat sig vanligt 
hos S. equi och S. zooepidemicus. ECM är ett olösligt nätverk som separerar 
och stöttar organ och vävnad i en organism. Två vanligt förekommande 
proteiner i ECM är fibronektin (Fn) och kollagen (Cn). Tidigare studier har 
identifierat att S. equi och S. zooepidemicus producerar flera kollagen- och 
fibronektin bindande proteiner (Lindmark 1996,Lindmark 2001, Lannergård 
2005). I artikel II har vi identifierat en familj av gener som kodar för 
fibronektin- och/eller kollagen bindande proteiner, kallade FNE-liknande 
proteiner som inkluderar FNE, FNEB, FNEC, FNED, FNEE och FNEF.
Genom att producera dessa som rekombinanta proteiner har förmågan att binda 
till fibronektin och kollagen studerats. För att ytterligare kartlägga bindningen 
till respektive värdprotein har ett antal trunkeringar, eller förkortningar, av de 
rekombinanta proteinerna framställts. För att identifiera de bindande 
domänerna i respektive bakterieprotein samt hos de strukturella 
värdproteinerna Fn och Cn har flera olika tekniker används så som jod-in 
märkning av proteiner, mikrotiterplatta analyser samt cellbiologiska försök för 
studier av proteinernas funktion in vivo. Fyra av proteinerna tros vara cell 
väggs bundna proteiner medan två skickas ut i omgivningen. Bindningsstudier 
visade att två av proteinerna, FNE och FNEE, binder både Cn och Fn medan
tre, FNEC,FNED och FNEF, endast binder till Cn. FNEB binder endast till Fn. 
In vivo försök med eukaryota fibroblaster visade att, inte bara FNE ger upphov 
till kontraktioner av celler i en kollagen-kontraktions modell, utan även FNEE 
har liknande inverkan.  
Vissa patogena bakterier har utvecklat olika mekanismer för att undgå 
värdens immunförsvar, t.ex. genom att producera proteiner som interagerar 
med immunförsvaret. Immunoglobulin G (IgG) har en central roll i 
immunförsvaret för att skydda värden mot bakterier och andra 
mikroorganismer. När IgG binder till bakterier fungerar det som en 
signalflagga för immunförsvaret att en främmande bakterie finns i kroppen 
som måste oskadliggöras genom fagocytos eller genom komplement 
aktivering. Tidigare studier har visat att både S. equi och S. zooepidemicus
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producerar extracellulära enzymer vilka specifikt klyver IgG. Enzymerna 
kallade IdeE (S. equi) och IdeZ (S. zooepidemicus) bryter ner/ klipper sönder 
IgG molekyler från olika däggdjur mycket effektivt (Lannergård 2006). En 
annan studie har visat IdeE även kan interagera med neutrofiler från häst 
genom att binda in via en integrin bindande del hos IdeE (Timoney 2008).
I artikel I visade vi på att S. equi och S. zooepidemicus har minst ytterligare 
två IgG klyvande enzym kallade IdeE2 och IdeZ2. Dessa enzymer klyver IgG 
från människa och häst mycket effektivt men inte IgG från andra mammalier. I 
studien visade vi att IdeE2 klyver en speciell grupp av häst IgG, IgG4 (IgGb) 
som finns närvarande i häst serum. För att ta reda på om IdeE och IdeE2 passar 
som komponenter i ett framtida vaccin mot kvarka immuniserades möss med 
enzymerna varefter de blev utsatta för S. equi. Vaccinationsstudien visade att 
båda enzymerna ger ett bra skydd mot S. equi i en musmodell av kvarka. 
Eftersom IdeE2 inte i klyvnings studier av IgG visat aktivitet mot mus IgG var
skyddseffekten av detta enzym i mus modellen lite överraskande men det kan 
inte uteslutas att IdeE2 har andra funktioner hos bakterien. I studien upptäcktes 
att genen för IdeZ2 proteinet varierade i gensekvensen och att det finns tre 
olika varianter av genen (artikel III). Variationen kunden inte härledas till 
vilken typ av infektion den orsakat, alltså om det var från djur med 
luftvägsinfektion, infektion i livmodern eller en sårinfektion, eller från vilken 
typ av streptokock stam bakterien tillhörde. De olika IdeZ2 proteinerna hade 
fortfarande samma klyvningsförmåga dvs. att alla varianterna klyver häst IgG 
väldigt effektivt. 
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